Literature DB >> 495696

The behavioral and neuropathologic sequelae of intoxication by trimethyltin compounds in the rat.

A W Brown, W N Aldridge, B W Street, R D Verschoyle.   

Abstract

Trimethyltin, when given by gavage to rats, has an LD50 of 12.6 mg/kg. Signs of poisoning include tremors, hyperexcitability, aggressive behavior, weight loss, and convulsions. After single (10 mg/kg) or repeated weekly doses (a maximum of four) of 4 mg/kg, rats, up to a survival time of 70 days, were perfusion-fixed for light microscopy. Trimethyltin was assayed in brain and blood in rats after similar treatments. Trimethyltin is cumulative and persistent and binds with high affinity to hemoglobin. Trimethyltin, unlike triethyltin, does not produce white matter edema in rats but does cause bilateral and symmetrical neuronal alterations involving the hippocampus (largely sparing the Sommer sector), pyriform cortex, amygdaloid nucleus, and neocortex. The earliest alteration was loss or dispersal of Nissl substance, then clumping of nuclear chromatin, followed by shrinkage and fragmentation of the nucleus within shrunken eosinophilic cytoplasm. These changes were associated with approximately 1.4 microgram trimethyltin/g wet weight in brain tissue 1 day after the second dose of 4 mg/kg or 2 days after a single dose of 10 mg/kg. Signs of poisoning gradually disappeared, and 4 rats surviving 70 days appeared normal, although their brains had severe damage with cell loss in the hippocampi and each pyriform cortex. Treatment of rats with trimethyltin, therefore, provides a chronic preparation with consistent lesions in the hippocampus of use in other behavioral and neuroanatomic studies. (Am J Pathol 97:59--82, 1979).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495696      PMCID: PMC2042375     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  ACTIVE AND INACTIVE REGIONS OF NUCLEAR CHROMATIN AS REVEALED BY ELECTRON MICROSCOPE AUTORADIOGRAPHY.

Authors:  V C LITTAU; V G ALLFREY; J H FRENSTER; A E MIRSKY
Journal:  Proc Natl Acad Sci U S A       Date:  1964-07       Impact factor: 11.205

2.  Studies on the toxicity of alkyl tin compounds.

Authors:  H B STONER; J M BARNES; J I DUFF
Journal:  Br J Pharmacol Chemother       Date:  1955-03

3.  Further studies on the toxicity of some tetra and trialkyl lead compounds.

Authors:  J E CREMER; S CALLAWAY
Journal:  Br J Ind Med       Date:  1961-10

4.  Hippocampal lesions following administration of 3-acetylpyridine.

Authors:  R E COGGESHALL; P D MACLEAN
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

5.  The toxicology of tin compounds.

Authors:  J M BARNES; H B STONER
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

6.  Biochemical studies on the toxicity of tetraethyl lead and other organo-lead compounds.

Authors:  J E CREMER
Journal:  Br J Ind Med       Date:  1959-07

7.  Anoxic-ischemic encephalopathy in rats.

Authors:  S LEVINE
Journal:  Am J Pathol       Date:  1960-01       Impact factor: 4.307

8.  The biochemistry of organotin compounds; the conversion of tetraethyltin into triethyltin in mammals.

Authors:  J E CREMER
Journal:  Biochem J       Date:  1958-04       Impact factor: 3.857

9.  Determination of circulating red cell volume by radioactive chromium.

Authors:  S J GRAY; K STERLING
Journal:  Science       Date:  1950-08-11       Impact factor: 47.728

10.  Toxic properties of some dialkyl and trialkyl tin salts.

Authors:  J M BARNES; H B STONER
Journal:  Br J Ind Med       Date:  1958-01
View more
  33 in total

1.  Changes in APP, PS1 and other factors related to Alzheimer's disease pathophysiology after trimethyltin-induced brain lesion in the rat.

Authors:  Camilla Nilsberth; Beata Kostyszyn; Johan Luthman
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

2.  Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells.

Authors:  Armando Varela-Ramirez; Margaret Costanzo; Yazmin P Carrasco; Keith H Pannell; Renato J Aguilera
Journal:  Cell Biol Toxicol       Date:  2010-10-31       Impact factor: 6.691

3.  Quantitative mapping of trimethyltin injury in the rat brain using magnetic resonance histology.

Authors:  G Allan Johnson; Evan Calabrese; Peter B Little; Laurence Hedlund; Yi Qi; Alexandra Badea
Journal:  Neurotoxicology       Date:  2014-03-11       Impact factor: 4.294

4.  Trimethyltin induced hippocampal lesions at various neonatal ages.

Authors:  L W Chang
Journal:  Bull Environ Contam Toxicol       Date:  1984-09       Impact factor: 2.151

Review 5.  Toxic substances and the nervous system: the role of clinical observation.

Authors:  P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

6.  The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.

Authors:  T Maurice; V L Phan; Y Noda; K Yamada; A Privat; T Nabeshima
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

7.  Regional variations in nerve cell responses to trimethyltin intoxication in Mongolian gerbils and rats; further evidence for involvement of the Golgi apparatus.

Authors:  C C Nolan; A W Brown; J B Cavanagh
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  Endogenous excitatory amino acid release from brain slices and astrocyte cultures evoked by trimethyltin and other neurotoxic agents.

Authors:  R Dawson; T A Patterson; B Eppler
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

9.  Sex-specific Changes in Brain Estrogen Metabolism Induced by Acute Trimethyltin Exposure.

Authors:  Jung Ho Lee; Sung-Hee Cho; Eun Hye Jang; Soon Ae Kim
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

10.  The sequential magnetic resonance images of tri-methyl tin leukoencephalopathy.

Authors:  Chang Ho Hwang
Journal:  Neurol Sci       Date:  2009-02-03       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.